4/8/2008 9:15:15 AM
MATTAWAN, Mich.--(BUSINESS WIRE)--Medicilon/MPI Preclinical Research Shanghai has announced its newly formed Board of Directors, which has equal representation from the two parent companies. The four directors include executives William U. Parfet and William Harrison from MPI Research, and Drs. Chun-Lin Chen and Jintao Zhang from Medicilon.
comments powered by